-
公开(公告)号:US20160017007A1
公开(公告)日:2016-01-21
申请号:US14770919
申请日:2014-03-11
发明人: Matthew WALDOR , Xiaohui ZHOU , Benjamin GEWURZ
CPC分类号: C07K14/28 , A61K35/74 , A61K39/02 , C07K2319/00 , C07K2319/20 , C07K2319/31 , C07K2319/40 , C07K2319/50 , C07K2319/60
摘要: Embodiments described are immunosuppressant therapeutics and compositions comprising a Vop protein derived from Vibro parahaemolyticus; and drug delivery vehicles derived from a V. parahaemolyticus expressing a mutant VopZ protein lacking amino acid residue 38-62.
摘要翻译: 所描述的实施方案是免疫抑制剂治疗剂和包含源自副溶血弧菌的Vop蛋白的组合物; 来自副溶血性弧菌的药物递送载体,其表达缺少氨基酸残基38-62的突变型VopZ蛋白。